A 2019 clip of Bill Gates discussing CRISPR technology is used to explore the shift in terminology from "strains" to "variants." The hosts suggest that the use of mRNA technology and PCR testing is being leveraged to maintain high case numbers by identifying common cold mutations as COVID-19.


